SHANGHAI FUDAN-ZHANGJIAN BIO-PHARMSHANGHAI FUDAN-ZHANGJIAN BIO-PHARMSHANGHAI FUDAN-ZHANGJIAN BIO-PHARM

SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM

No trades
See on Supercharts

1349 fundamentals

An in-depth look to SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM operating, investing, and financing activities

1349 free cash flow for Q3 24 is -103.97 M HKD. For 2023, 1349 free cash flow was -30.89 M HKD and operating cash flow was 78.47 M HKD.

Q4 '11
Q1 '12
Q2 '12
Q3 '12
Q4 '12
Q1 '13
Q2 '13
Q3 '13
Q2 '14
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
Q4 '11
Q1 '12
Q2 '12
Q3 '12
Q4 '12
Q1 '13
Q2 '13
Q3 '13
Q2 '14
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Free cash flowYoY growth